Submission Details
| 510(k) Number | K171404 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 12, 2017 |
| Decision Date | July 17, 2017 |
| Days to Decision | 66 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K171404 is an FDA 510(k) clearance for the BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B), a Lens, Contact (other Material) - Daily (Class II — Special Controls, product code HQD), submitted by Bausch & Lomb, Incorporated (Rodchester, US). The FDA issued a Cleared decision on July 17, 2017, 66 days after receiving the submission on May 12, 2017. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.5916.
| 510(k) Number | K171404 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 12, 2017 |
| Decision Date | July 17, 2017 |
| Days to Decision | 66 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | HQD — Lens, Contact (other Material) - Daily |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.5916 |